GeneDx · 23 hours ago
Epic Analyst
GeneDx, the world’s leading genomic diagnostics company, is seeking an experienced Epic Analyst to support Epic Aura integrations from build through post go-live support. In this role, you will join the cross-functional Epic Aura team, owning and maintaining GeneDx's Epic application, ensuring all configuration, security, and user requirements meet the needs of our end users and our business.
AnalyticsArtificial Intelligence (AI)Health CareHealth DiagnosticsMachine LearningMedicalPredictive Analytics
Responsibilities
Act as the primary point of contact for Epic Aura application needs
Collaborate with engineering, commercial, and operational teams, as well as other Epic specialists, to troubleshoot, identify, and solve issues with our Epic integrations
Guide workflow design, build and test the system, and analyze other technical issues associated with Epic software
Work with Epic representatives, your GeneDx teammates, and customers to ensure the system meets the required project deliverables and timeline
Enable smooth customer integration projects by establishing and maintaining documentation about our Epic implementation
Qualification
Required
2+ years of experience working with Epic applications
Strong knowledge of healthcare provider workflows and the software and people/staff that enable them
Familiarity with healthcare data models and standards, like HL7 and FHIR
Highly organized, with a demonstrated technical build experience
Strong communication skills, both written and verbal
High drive for understanding and solving customer needs
Ability to learn quickly, think creatively, and adapt to change under pressure to meet deadlines
Active Epic certification is required (IE: Ambulatory, Care Everywhere, and Beaker)
Ability to stand, walk, and sit for extended periods
Preferred
Experience with genomics labs is a plus
Benefits
Paid Time Off (PTO)
Health, Dental, Vision and Life insurance
401k Retirement Savings Plan
Employee Discounts
Voluntary benefits
Company
GeneDx
GeneDx uses artificial intelligence and machine learning to analyze patient data to provide insights to transform the practice of medicine.
Funding
Current Stage
Public CompanyTotal Funding
$941MKey Investors
BlackRock Innovation Capital
2023-01-26Post Ipo Equity· $150M
2023-01-10IPO
2022-01-18Post Ipo Equity· $200M
Recent News
Company data provided by crunchbase